|Bid||59.75 x 1000|
|Ask||59.90 x 800|
|Day's Range||58.70 - 59.69|
|52 Week Range||46.55 - 69.92|
|PE Ratio (TTM)||17.16|
|Forward Dividend & Yield||3.16 (5.46%)|
|1y Target Est||N/A|
In a story Aug. 6 story listing female CEO of S&P 500 companies, The Associated Press erroneously listed Margaret C. Whitman as the CEO of Hewlett Packard Enterprise Co. She stepped down from the role ...
Ventas (VTR) delivered earnings and revenue surprises of 5.88% and 2.57%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
The Chicago-based real-estate investment company’s second-quarter profit rose to $166.5 million, or 46 cents a share, from $151.8 million, or 42 cents a share, a year ago
Ventas (VTR) is slated to report its second-quarter results on July 27. Wall Street expects its results to be mixed, with revenue rising 1.6% YoY (year-over-year) to $910.2 million and AFFO (adjusted funds from operations) per share falling 2.9%. The segment is struggling with market oversupply, which is impacting its pricing power, average occupancy rate, and monthly REVPOR (revenue per occupied room).
AvalonBay (AVB) Q2 results likely to reflect benefits from favorable demographics and job growth. However, rising supply remains a drag.
Ventas' (VTR) Q2 performance expected to reflect favorable impact of the rising aging population as well as the company's strategic agreement with Brookdale.
When stocks were showing a larger sign of selling off, we had the $13.50 level on watch for Advanced Micro Devices, Inc. (NASDAQ:AMD). The problem is, as that trend-line continues to fall as downtrend lines tend to do, our buy trigger falls lower and lower. If AMD stock is truly in demand, it may no longer be a realistic target.
Traders looking for higher-odds trading prospects, however, will want to look at Express Scripts Holding Co (NASDAQ:ESRX), Alexion Pharmaceuticals (NASDAQ:ALXN) and Ventas (NYSE:VTR) … each of which are actually getting into a bullish groove despite Tuesday’s lull. The wave of M&A within the healthcare arena, and within the pharmaceutical distribution sliver of the market in particular, has been a blessing and a curse for Express Scripts Holding. • The monthly chart indicates that the bullish move in December not only broke above a falling resistance line that had extended back to 2015’s peak, but has put a string of higher highs and higher lows in place.
Stocks looked like they might be able to gain some momentum in early trading Wednesday, but those gains faded as investors clearly aren’t reaching for equities as they head into the third quarter. That’s left a number of interesting setups as we eye our top stock trades for Thursday.Top Stock Trades for Tomorrow #1: Micron (MU)
On the 12 July 2018, Ventas Inc (NYSE:VTR) will be paying shareholders an upcoming dividend amount of US$0.79 per share. However, investors must have bought the company’s stock before 29Read More...
Stocks took a beating on Monday, with the Nasdaq falling over 2.5% and the Dow Jones falling almost 2% on more fears over a trade war. How does that impact our top stock trades going forward?Top Stock Trades for Tomorrow #1: Amazon (AMZN)